A simple blood test could predict which patients with the lung-scarring disease known as idiopathic pulmonary fibrosis (IPF) are soon to get far worse, an indicator that could one day influence their treatment, according to researchers. Their findings indicate that the body’s immune cells attack healthy lung tissue, suggesting that IPF is in fact an immunologic disease.